MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jha2.856

Медицинская библиотека · EJHaem · 2024

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.

Pemmaraju Naveen, Cuglievan Branko, Lasky Joseph, Kheradpour Albert, Hijiya Nobuko, Stein Anthony S, Meshinchi Soheil, Mullen Craig A, Angelucci Emanuele, Vinti Luciana, Mughal Tariq I, Pawlowska Anna B

СтатьяПеревод пока не подготовлен

Аннотация

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10-20% of cases are pediatric or adolescent/young adult (AYA) patients. Tagraxofusp (TAG, Elzonris®) is the only approved treatment for BPDCN; in the United States it is approved for patients aged ≥2 years. Data on treating pediatric and AYA BPDCN patients are limited. We present a case series of pediatric and AYA patients with BPDCN treated with TAG. Eight patients (five newly diagnosed; three relapsed/refractory [R/R]), aged 2-21 years, received 12 mcg/kg TAG. Seven patients were female; most had skin (n = 6) and/or bone marrow (n = 4) involvement. No new safety signals were identified. Grade 3 adverse events were headache (n = 1) and transaminitis (n = 2). Three patients with newly diagnosed BPDCN achieved complete response, one achieved partial response, and one had stable disease (SD). One patient with R/R BPDCN achieved a minor response; one had SD. Seven patients (88%) were bridged to stem cell transplant: 80% of newly diagnosed patients and 100% of R/R patients. Five patients remained alive at last follow-up. These cases highlight the efficacy and safety of TAG in pediatric and AYA patients for whom there is no other approved BPDCN therapy.

Для цитирования: Pemmaraju Naveen, Cuglievan Branko, Lasky Joseph, Kheradpour Albert, Hijiya Nobuko, Stein Anthony S, Meshinchi Soheil, Mullen Craig A, Angelucci Emanuele, Vinti Luciana, Mughal Tariq I, Pawlowska Anna B. Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.. EJHaem. 2024. DOI: 10.1002/jha2.856.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.